Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in elderly people is usually mild and responds well to treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Erdr1 could be a new marker for diagnosing hair loss.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Alopecia areata involves immune response and gene changes affecting hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.